Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1401 to 1450 of 2518

TitleReference numberPublishedLast updated
Cataracts in adults: managementNG77
Cystic fibrosis: diagnosis and managementNG78
Hepatitis B (chronic): diagnosis and managementCG165
PleuraFlow Active Clearance Technology for maintaining chest tube patencyMIB125
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Immunosuppressive therapy for kidney transplant in adultsTA481
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Cerebral palsy in children and young peopleQS162
Child abuse and neglectNG76
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Reslizumab for treating severe eosinophilic asthmaTA479
Thora-3Di for assessing asthma in childrenMIB122
Memokath-028, 044 and 045 stents for urethral obstructionMIB123
FreeStyle Libre for glucose monitoringMIB110
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone diseaseIPG593
Faltering growth: recognition and management of faltering growth in childrenNG75
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Intermediate care including reablementNG74
Caris Molecular Intelligence for guiding cancer treatmentMIB120
Type 2 diabetes: prevention in people at high riskPH38
Ab externo canaloplasty for primary open-angle glaucomaIPG591
High-intensity focused ultrasound for symptomatic breast fibroadenomaIPG592
Aptiva for painful diabetic neuropathyMIB119
Transition between inpatient mental health settings and community or care home settingsQS159
End of life care for infants, children and young peopleQS160
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapyTA428
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumabTA357
Pembrolizumab for advanced melanoma not previously treated with ipilimumabTA366
Physical health of people in prisonsQS156
HIV testing: encouraging uptakeQS157
Rehabilitation after critical illness in adultsQS158
Fertility problems: assessment and treatmentCG156
Sorafenib for treating advanced hepatocellular carcinomaTA474
Dimethyl fumarate for treating moderate to severe plaque psoriasisTA475
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancerTA476
Psoriasis: assessment and managementCG153
Fungitell for antifungal treatment stratificationMIB118
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neckTA473
Vitamin D: supplement use in specific population groupsPH56
Radiofrequency treatment for haemorrhoidsIPG589
Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal)TA468
Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal)TA469
Holoclar for treating limbal stem cell deficiency after eye burnsTA467
Pemetrexed for the maintenance treatment of non-small-cell lung cancerTA190
Biopatch for venous or arterial catheter sitesMIB117
Developmental follow-up of children and young people born pretermNG72
Cabozantinib for previously treated advanced renal cell carcinomaTA463
Baricitinib for moderate to severe rheumatoid arthritisTA466
Urethrotech UCD for difficult or failed catheterisationMIB116

Results per page

  1. 10
  2. 25
  3. 50
  4. All